Schroder ISF* Healthcare Innovation
Investing in the world’s healthOur approach
A global equity portfolio that gives investors the opportunity to participate in a theme that is important to all of us – our health. A new wave of innovation is transforming healthcare across its various strands. And the benefits are clear.
Schroder ISF* Healthcare Innovation is a global equity portfolio that gives investors the opportunity to participate in a theme that is important to all of us – our health. A new wave of innovation is transforming healthcare across its various strands. And the benefits are clear.
View fund information
Why Invest?
Across the world, we are living longer – this is due to rapid advances in healthcare science, new procedures and better use of data science and computing power. At the same time, an increasing focus on healthy living and improved well-being has never been more in the spotlight. Although traditionally seen as a source of relatively defensive growth, the rapid pace of change across the healthcare sector has transformed it into a diverse pool of rich growth opportunities.
Broad and deep experience investing in healthcare
We’ve been managing healthcare portfolios since 2000. Our team of 5 healthcare specialists have over 90 years of combined investment experience and looks after US $10 bn of healthcare assets.
Focused, yet diverse portfolio for long-term returns
Healthcare offers broad investment opportunities. We look across the sector to construct a portfolio with 50 to 70 stocks that reflect our best ideas. The outcome of this portfolio is aimed to be diverse enough to deliver steady returns over the long-term.
Harnessing the power of data
While traditional research is a key component of our process, our Data Insights Unit provide additional insight. A team of 20+ data scientists, statisticians and mathematicians supplement traditional financial data with alternative data sets and techniques, including artificial intelligence and machine learning to find companies that shape the future of healthcare.
Looking deeper than the tip of the iceberg
Opportunities in healthcare go beyond news headlines. We look broadly across five healthcare sub-sectors to construct our optimal portfolio.
Meet the manager
Risk considerations
*Schroder International Selection Fund is referred to as Schroder ISF.
- Concentration risk: The fund may be concentrated in a limited number of geographical regions, industry sectors, markets and/or individual positions. This may result in large changes in the value of the fund, both up or down.
- Counterparty risk: The fund may have contractual agreements with counterparties. If a counterparty is unable to fulfil their obligations, the sum that they owe to the fund may be lost in part or in whole.
- Currency risk: If the fund’s investments are denominated in currencies different to the fund’s base currency, the fund may lose value as a result of movements in foreign exchange rates, otherwise known as currency rates. If the investor holds a share class in a different currency to the base currency of the fund, investors may be exposed to losses as a result of movements in currency rates.
- Currency risk / hedged share class: The currency hedging of the share class may not be fully effective and residual currency exposure may remain. The cost associated with hedging may impact performance and potential gains may be more limited than for unhedged share classes.
- Derivatives risk: Derivatives, which are financial instruments deriving their value from an underlying asset, may be used to manage the portfolio efficiently. A derivative may not perform as expected, may create losses greater than the cost of the derivative and may result in losses to the fund.
- Liquidity Risk: In difficult market conditions, the fund may not be able to sell a security for full value or at all. This could affect performance and could cause the fund to defer or suspend redemptions of its shares, meaning investors may not be able to have immediate access to their holdings.
- Market risk: The value of investments can go up and down and an investor may not get back the amount initially invested.
- Operational Risk: Operational processes, including those related to the safekeeping of assets, may fail. This may result in losses to the fund.
- Performance risk: Investment objectives express an intended result but there is no guarantee that such a result will be achieved. Depending on market conditions and the macro economic environment, investment objectives may become more difficult to achieve.
- Sustainability risk: TheThe fund has environmental and/or social characteristics. This means it may have limited exposure to some companies, industries or sectors and may forego certain investment opportunities, or dispose of certain holdings, that do not align with its sustainability criteria chosen by the investment manager. The fund may invest in companies that do not reflect the beliefs and values of any particular investor.
Important information:
For professional investors and advisers only. The material is not suitable for retail clients. We define "Professional Investors" as those who have the appropriate expertise and knowledge e.g. asset managers, distributors and financial intermediaries.
This document does not constitute an offer to anyone, or a solicitation by anyone, to subscribe for shares of Schroder International Selection Fund (the “Company”). Nothing in this document should be construed as advice and is therefore not a recommendation to buy or sell shares. An investment in the Company entails risks, which are fully described in the prospectus. Subscriptions for shares of the Company can only be made on the basis of its latest Key Information Document and prospectus, together with the latest audited annual report (and subsequent unaudited semi-annual report, if published), copies of which can be obtained, free of charge, from Schroder Investment Management (Europe) S.A.
Disclosures and Risk Factors
Collective investment schemes are generally medium to long-term investments.
The value of participatory interests or the investment may go down as well as up.
Past performance is not necessarily a guide to future performance.
Collective investment schemes are traded at ruling prices and can engage in borrowing and scrip lending.
A schedule of fees and charges and maximum commissions is available on request from the manager.
The manager does not provide any guarantee either with respect to the capital or the return of a portfolio.
The manager has a right to close the portfolio to new investors in order to manage it more efficiently in accordance with its mandate.
Issued in March 2025 by Schroders Investment Management Ltd registration number: 01893220 (Incorporated in England and Wales) is authorised and regulated in the UK by the Financial Conduct Authority and an authorised financial services provider in South Africa FSP No: 48998.
This is a Section 65 approved fund under the Collective Investment Schemes Control Act 45, 2002 (CISCA). Boutique Collective Investments (RF) (Pty) Ltd is the South African Representative Office for this fund. Boutique Collective Investments (RF) (Pty) Ltd is registered and approved under the Collective Investment Schemes Control Act (No.45 of 2002).